Dr. Jens Kurreck

Biography

Jens Kurreck leads the field of Applied Biochemistry at Technische Universität Berlin, focusing on improving the human relevance of biomedical research through the development of alternative methods to animal testing and innovative therapeutic approaches. His research emphasizes the creation of new replacement models for animal experiments utilizing three-dimensional bioprinting to develop organ models for infection research. These models, which incorporate human cells, provide greater relevance for human diseases compared to animal models. His work includes investigating anticancer drugs and antiviral substances, particularly through the use of RNA technologies like RNA interference, which allows for the specific suppression of gene expression. Notably, he has identified highly efficient small interfering RNA (siRNA) against SARS-CoV-2. Additionally, he is involved in developing oncolytic viruses that specifically inhibit tumor growth and the formation of metastases. In education, he contributes to the Biotechnology program by teaching foundational Biochemistry and advanced Molecular Medicine courses. Kurreck also serves as the co-speaker of the Einstein Centers 3R and champions sustainability principles in research and teaching at his department, which has received the highest sustainability label from Green Lab.

Research Interests